Aigen Investment Management, LP Acadia Pharmaceuticals Inc Transaction History

Aigen Investment Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$14.62 - $18.42 $489,448 - $616,664	-33,478 Reduced 66.28%	17,030 $276,000
Q1 2024 May 14, 2024	SELL	$17.79 - $30.86 $35,811 - $62,121	-2,013 Reduced 3.83%	50,508 $933,000
Q4 2023 Feb 09, 2024	BUY	$20.78 - $31.77 $778,314 - $1.19 Million	37,455 Added 248.61%	52,521 $1.64 Million
Q3 2023 Nov 13, 2023	BUY	$20.84 - $33.47 $313,975 - $504,259	15,066 New	15,066 $313,000
Q4 2020 Feb 12, 2021	SELL	$41.04 - $56.79 $835,574 - $1.16 Million	-20,360 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$36.42 - $57.0 $741,511 - $1.16 Million	20,360 New	20,360 $840,000

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.